Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Trying to understand Moores' response on claim 29.

I'm not sure I agree based on CM's own statement. The first sentence appears to be a statement of confusion concerning the enterpretation of the claim. In the second sentence he offers everyone the chance to examine it for themselves. Didn't anyone else find it strange that the USPTO abruptly dropped the re-exam and issued a re-cert once TPL agreed to the amendment? Mr. Moore's statement makes it appear that the amended claim is now vague at best. How does that aid use in chasing potential infringers? Nathan Hale, Ease(Your contact), Emtnester---anyone have any thoughts?

"Really hard to know what Claim 29 says. I've added it to the Moore v TPL page."

Share
New Message
Please login to post a reply